NOREPINEPHRINE BITARTRATE
Active substance: norepinephrine bitartrate
INJECTION, SOLUTION · NOREPINEPHRINE BITARTRATE 16 mg/250mL
United StatesActive
Marketing holder: Baxter Healthcare Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- NOREPINEPHRINE BITARTRATE · 16 mg/250mL
Registration
- Registration number
- 0338-0128
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0338-0128 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0338-0128 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0338-0128 · Verified 2026-10-09 · open in source